Biotech

Helix BioPharma Corp. to Present at the Twenty Seventh International Papillomavirus Conference and Clinical Workshop

AURORA, ON: ...

Peregrine Pharmaceuticals Reports First Quarter Fiscal Year 2012 Financial Results and Recent Developments

TUSTIN, CA: Enrollment Complete in Randomized Phase II Non-Small Cell Lung Cancer Trial, Advancing Three Phase II Programs in Oncology and HCV Infection ...

Marina Biotech, Inc. to Present at the Rodman & Renshaw 13th Annual Healthcare Conference

BOTHELL, WA: ...

Cleveland BioLabs to Present at Rodman & Renshaw 13th Annual Healthcare Conference

BUFFALO, NY: ...

Theratechnologies Launches Phase 2 Clinical Trial to Investigate Tesamorelin for the Treatment of COPD-Associated Muscle Wasting

MONTREAL, QUEBEC: ...

Late-Stage Products From BioSante and Keryx Gaining Momentum

NEW YORK, NY: The Bedford Report Provides Equity Research on BioSante & Keryx Biopharmaceuticals ...

Aposense Cancer Drug Demonstrates 100% Oral Bioavailability in New Study

PETACH-TIKVA, ISRAEL: Animal Study of Anticancer Agent ATT-11T -- a New Irinotecan Analogue -- Could Lead to Clinical Trials ...

ProMetic BioSciences Ltd Provides Corporate Update

ISLE OF MAN, UNITED KINGDOM: - $0.8 million working capital grant from the Isle of Man Government received to support revenue growth - Revenues from PBL operations expected to exceed $6.0 million in H2 2011 - 5th consecutive yea ...

Pacgen Announces Private Placement Financing

VANCOUVER, BRITISH COLUMBIA: ...

Medicopia Life Sciences: A Powerful, New Approach to Pain Therapy

MONTREAL, QUEBEC: Health Canada approves new line of safe, effective, 100% natural, Canadian-made medications from Medicopia(TM) ...